Home

Снежанка тъмнина накрая polo like kinase 4 сапун Едновременно показване кредитор

Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect

Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer  Therapy, with a Focus on NSCLC | Clinical Cancer Research
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research

Role for polo-like kinase 4 in mediation of cytokinesis | PNAS
Role for polo-like kinase 4 in mediation of cytokinesis | PNAS

Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS
Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS

PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma  Associates with Poor Prognosis
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis

Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham  Science
Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science

Localization and expression of polo-like kinase (PLK)4 during meiotic... |  Download Scientific Diagram
Localization and expression of polo-like kinase (PLK)4 during meiotic... | Download Scientific Diagram

Autoinhibition and relief mechanism for Polo-like kinase 4 – The Quan Lab
Autoinhibition and relief mechanism for Polo-like kinase 4 – The Quan Lab

Rabbit anti-Human PLK4 antibody (ABIN2682502)
Rabbit anti-Human PLK4 antibody (ABIN2682502)

Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy? -  ScienceDirect
Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy? - ScienceDirect

PDF) Polo-like kinase 4 activity limits centrosome overduplication by  autoregulating its own stability
PDF) Polo-like kinase 4 activity limits centrosome overduplication by autoregulating its own stability

Molecules | Free Full-Text | Development of Highly Selective  1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box  Domain-binding Inhibitors
Molecules | Free Full-Text | Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors

Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of  lung cancers | PNAS
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers | PNAS

PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma  Associates with Poor Prognosis
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis

Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research
Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research

Polo-like kinases: structural variations lead to multiple functions |  Nature Reviews Molecular Cell Biology
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology

Polo-like kinase 4: the odd one out of the family | Cell Division | Full  Text
Polo-like kinase 4: the odd one out of the family | Cell Division | Full Text

Polo-like Kinase 4 Shapes Up - ScienceDirect
Polo-like Kinase 4 Shapes Up - ScienceDirect

Figure 3 from Polo-like kinase 4: the odd one out of the family | Semantic  Scholar
Figure 3 from Polo-like kinase 4: the odd one out of the family | Semantic Scholar

Polo-like Kinase Inhibitor V, Poloxin - CAS 321688-88-4 - Calbiochem The  Polo-like Kinase Inhibitor
Polo-like Kinase Inhibitor V, Poloxin - CAS 321688-88-4 - Calbiochem The Polo-like Kinase Inhibitor

The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? |  Cancer Research
The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? | Cancer Research

Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer  Therapy, with a Focus on NSCLC | Clinical Cancer Research
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research

Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy? - ppt download
Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy? - ppt download

Goat anti-Human PLK4 antibody (ABIN184701)
Goat anti-Human PLK4 antibody (ABIN184701)

APExBIO - CFI-400945 orally available, selective inhibitor of polo-like  kinase 4 (PLK4) | CAS# 1338800-06-8
APExBIO - CFI-400945 orally available, selective inhibitor of polo-like kinase 4 (PLK4) | CAS# 1338800-06-8